Cargando…
Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes
Detection of serum tumor markers has been developed as a non-invasive tool to assess treatment efficiency in different types of cancer. This study aims to investigate the role of preoperative serum tumor markers (CEA, CA125 and CA15-3) in the management of breast cancer, and their relationships with...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609976/ https://www.ncbi.nlm.nih.gov/pubmed/28969044 http://dx.doi.org/10.18632/oncotarget.19246 |